A randomised controlled clinical trial to assess the benefits of a telecare tool delivered prior to the initial hearing assessment

Int J Audiol. 2023 May;62(5):400-409. doi: 10.1080/14992027.2022.2059713. Epub 2022 Apr 18.

Abstract

Objective: To assess the benefits of the Ida Institute's Why improve my hearing? Telecare Tool used before the initial hearing assessment appointment.

Design: A prospective, single-blind randomised clinical trial with two arms: (i) Why improve my hearing? Telecare Tool intervention, and (ii) standard care control.

Study sample: Adults with hearing loss were recruited from two Audiology Services within the United Kingdom's publicly-funded National Health Service. Of 461 individuals assessed for eligibility, 57 were eligible to participate.

Results: Measure of Audiologic Rehabilitation Self-efficacy for Hearing Aids (primary outcome) scores did not differ between groups from baseline to post-assessment (Mean change [Δ]= -2.28; 95% confidence interval [CI]= -6.70, 2.15, p= .307) and 10-weeks follow-up (Mean Δ= -2.69; 95% CI= -9.52, 4.15, p = .434). However, Short Form Patient Activation Measure scores significantly improved in the intervention group compared to the control group from baseline to post-assessment (Mean Δ= -6.06, 95% CI= -11.31, -0.82, p = .024, ES= .61) and 10-weeks follow-up (Mean Δ= -9.87, 95% CI= -15.34, -4.40, p = .001, ES= -.97).

Conclusions: This study demonstrates that while a patient-centred telecare intervention completed before management decisions may not improve an individual's self-efficacy to manage their hearing loss, it can lead to improvements in readiness.

Keywords: Adult aural rehabilitation; randomised clinical trial; readiness; self-efficacy; telecare intervention.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cost-Benefit Analysis
  • Deafness*
  • Hearing
  • Hearing Loss* / rehabilitation
  • Humans
  • Prospective Studies
  • Quality of Life
  • Single-Blind Method
  • State Medicine

Associated data

  • ISRCTN/ISRCTN11296341